- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03000712
Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC Comared to Negative Control After High Tibial Osteotomy in the Osteoarthritis Patients.
Single-center, Randomized, Open Label, Negative-controlled Investigator Initiated Trial to Evaluate the Efficacy and Safety of Intra-articular Injection of ADMSC(Autologous Adipose Tissue Derived Mesenchymal Stem Cells) After High Tibial Osteotomy Compared to Negative Control in the Osteoarthritis Patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In this clinical trial, the investigational product is administered intra-articularly at 1 week after high tibial osteotomy in a patient with degenerative arthritis of the medial side.
The investigational product is autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissue and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection.
It primarily aims to regenerate cartilage, to improve pain and joint function. The intra-articular injection of the investigational product is expected to stimulate the regeneration and growth of cartilage, and to innovatively improve pain and joint function with cartilage regeneration compared to high tibial osteotomy alone.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 134-727
- KyungHee University Gangdong Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients must consent in writing to participate in the study by signing and dating an informed consent document
- Patients who can communicate (exclusion of anyone who cannot understand the questionnaire)
- between 20 years and 80 years of age
- BMI≤30
- Diagnosis of osteoarthritis by radiographic criteria of Kellgren and Lawrence grade 2-4
- Diagnosis of osteoarthritis by ACR(American College of Rheumatology Criteria) Global functional criteria : There is the pain of the knee and radiographic osteophyte and at least one of the following (1) age >50 years (2) Less than 30 minutes of morning stiffness (3) The friction When moving weighted the knee
- Patients who agree with contraception
- Patients who agree to stop the existing osteoarthritis treatment and to get enough washout periods until medication time
- Patients scheduled for High tibial osteotomy due to medial gonarthrosis
Exclusion Criteria:
- patients with osteoporosis
- Preparing for Pregnancy or Pregnant women or lactating mothers.
- Patients with positive human immunodeficiency (HIV), hepatitis B (HBV), hepatitis C (HCV), venereal disease research laboratory(VDRL)
- Patients with hypersensitivity to investigator product or investigational product component or those with a history
- Patients who had participated in other clinical trials within 12 weeks prior to this study
- Patients who received any drug by intra-articular injection for treatment within 2 months prior to this enrollment.
- Patients who experienced as the knee joint cartilage and stem cell therapy or failure to treat
- Patents who started or changed the physical therapy program established within 2 weeks before the start of the study or during the study(An established physical therapy program may continue for the duration of the trial, provided that it does not change in frequency and intensity)
- Patents included in the following specific risk groups that may influence safety and efficacy assessments at the discretion of the investigator:: septic arthtritis, rheumatic disease, gout, recurrent pseudogout, paget disease, joint fracture, alcaptonuria, acromegaly, hemochromatosis, wilson's disease, primary osteochondrosis, hereditary disorder(ex: hyperkinesia), collagen gene abnormality ,etc
- Patients who have clinically significant severe medical illnesses judged the principal investigator
- Patients who have been diagnosed with malignancy within 5 years before screening (except for patients who were completely remissioned three years before screening criteria)
- Patients who the principal investigator consider inappropriate for the clinical trial due to any other reasons
- Patients who received concomitant contraindications and who have not passed the prescribed wash-out period before participating in the clinical trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Autologous Adipose Tissue derived MSCs
Biological: Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml, 1 time injection(at 1week after high tibial osteotomy)
|
biological : Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml drug: saline solution
Other Names:
|
NO_INTERVENTION: No treatment
No treatment (after high tibial osteotomy)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI scan
Time Frame: 24 months
|
MRI perform to measure cartilage defect size change from baseline up to 27 weeks
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MRI scan
Time Frame: 15, 27 weeks, 18, 24 months
|
MRI perform to measure cartilage defect size change from baseline up to 15 weeks
|
15, 27 weeks, 18, 24 months
|
WOMAC score
Time Frame: 15, 27 weeks, 18, 24 months
|
Change in WOMAC Total score from baseline up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
WOMAC sub-scale
Time Frame: 15, 27 weeks, 18, 24 months
|
Change in WOMAC sub-scale from baseline up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
Kellgren & Lawrence grade
Time Frame: 15, 27 weeks, 18, 24 months
|
Change in Kellgren & Lawrence grade from baseline up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
EQ5D
Time Frame: 15, 27 weeks, 18, 24 months
|
Change in the score of EQ-5D from baseline up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
ROM
Time Frame: 15, 27 weeks, 18, 24 months
|
change from baseline in knee flexion Range of Motion(ROM) at 15,27 weeks by physical examination
|
15, 27 weeks, 18, 24 months
|
KOOS (Knee Injury & Osteoarthritis Outcome Score)
Time Frame: 15, 27 weeks, 18, 24 months
|
Symptoms, pain and functionality of the knee joint will be evaluated via the Knee Injury and Osteoarthritis Outcome Score (KOOS)
|
15, 27 weeks, 18, 24 months
|
PGIC(Patient Global Impression of Change)
Time Frame: 15, 27 weeks, 18, 24 months
|
The percentage of subjects who were evaluated as improved at 15 weeks and 27 weeks in the patient global impression of change
|
15, 27 weeks, 18, 24 months
|
PSQI(Pittsburgh Sleep Quality Index)
Time Frame: 15, 27 weeks, 18, 24 months
|
Change in PSQI from baseline up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
Biomarkers
Time Frame: 15, 27 weeks, 18, 24 months
|
Change from baseline in Biomarkers up to 15, 27 weeks
|
15, 27 weeks, 18, 24 months
|
Incidence of adverse reactions and characteristics associated with investigational product
Time Frame: 15, 27 weeks, 18, 24 months
|
15, 27 weeks, 18, 24 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HTO-MSCs
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Novartis PharmaceuticalsRecruitingSymptomatic Knee OsteoarthritisUnited States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
-
University of BathUniversity of Oxford; 3D Metal Printing Ltd; Versus ArthritisRecruitingMedial Knee OsteoarthritisUnited Kingdom
Clinical Trials on Autologous Adipose Tissue derived MSCs 1x10^8cells/3ml
-
R-BioCompletedKnee Osteoarthritis | Degenerative ArthritisKorea, Republic of
-
R-BioAsan Medical CenterCompletedRomberg's Disease | Progressive Hemifacial AtrophyKorea, Republic of
-
R-BioKorea University Anam HospitalCompletedSpinal Cord InjuryKorea, Republic of
-
R-BioKorea University Anam HospitalWithdrawnLumbar Intervertebral Disc DegenerationKorea, Republic of
-
R-BioPusan National University HospitalCompletedCritical Limb IschemiaKorea, Republic of
-
R-BioSMG-SNU Boramae Medical CenterCompletedAvascular Necrosis of the Femoral HeadKorea, Republic of
-
Seoul National University HospitalCompletedRotator Cuff DiseaseKorea, Republic of
-
R-BioNot yet recruitingKnee Arthritis | Degenerative ArthritisKorea, Republic of
-
R-BioCompletedKnee Osteoarthritis | Degenerative ArthritisKorea, Republic of
-
R-BioCompletedDegenerative ArthritisKorea, Republic of